Catheterization, Peripheral
Conditions
Interventions
This is a randomized, controlled, open, superiority, two-arm clinical trial. The intervention group will consist of 130 children who will receive flushing before and after medication administration an
E07.877
Sponsors
Universidade Estadual de Feira de Santana
Universidade Estadual de Feira de Santana
Eligibility
Age
1 Years to 14 Years
Inclusion criteria
Inclusion criteria: Age between 1 and 14 years old. Intravenous therapy peripherally for 48 hours or more. Use of a Short Peripheral Intravenous Catheter for intermittent or continuous medication administration
Exclusion criteria
Exclusion criteria: Children who request to withdraw their consent or whose parents no longer consent to their participation during follow-up and children who remove the Short Peripheral Intravenous Catheter accidentally or on their own will be excluded from the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a difference between the catheter dwell time between the control group and the intervention group. The dwell time will be measured from the date and time of insertion of the device until the moment of its removal. It will be described in hours | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find a difference between the occurrence of local complications between the control group and the intervention group. Complications will be identified based on two scales. For phlebitis, the Visual Phlebitis and Infusion Scale will be used. And for infiltration, the Pediatric PIV Infiltration Scale will be used, translated and validated for use in Brazil;It is expected to find a difference in the type of local complication between the control group and the intervention group. Complications will be described as occlusion, phlebitis and infiltration/extravasation. For phlebitis, the Visual Phlebitis and Infusion Scale will be used. And for infiltration, the Pediatric PIV Infiltration Scale will be used, translated and validated for use in Brazil;It is expected to find a difference between the time of development of local complications between the control group and the intervention group. The time for complications to develop will be measured by the difference between the date of removal due to complication and the date of insertion of the short peripheral intravenous catheter. Will be described for hours | — |
Countries
Brazil
Contacts
Public ContactErika de Souza
Universidade Estadual de Feira de Santana
Outcome results
None listed